What are the needs of Cochrane stakeholders to respond to global health crises?
Cochrane’s response to the COVID-19 pandemic in 2020 focused on relevant questions that informed healthcare decision-making and built on methods and quality processes established by Cochrane over the years. Stakeholders’ needs were at the heart of our successful response, and the need for high-quality evidence synthesis was paramount. In planning our continued response, there is an opportunity to reflect on how systematic reviews should be produced in the future. Do stakeholders need different types of reviews and novel ways of synthesizing diverse evidence? How can we unleash the potential of the data and syntheses produced in Cochrane Reviews to support future responses to global crises?
This session focused on the needs of policy-makers, consumers, funders, and producers of evidence. Four panellists discussed their views on Cochrane’s role in future response to global health crises, how systematic reviews should evolve to respond to stakeholders needs, what values Cochrane brings, and the potential challenges going forward.
This session was recorded during the 'Virtually Cochrane' conference, hosted by Cochrane UK and Cochrane Ireland, 20-22nd April 2021.
Panel
Karla Soares-Weiser
Editor in Chief, Cochrane Library
.
.
.
.
.
John Grove
Director of Quality Assurance for Norms & Standards, World Health Organization
.
.
.
Declan Devane
Director of Evidence Synthesis Ireland and Director of Cochrane Ireland
Maureen Smith
Chair of Cochrane’s Consumer Executive
.
.
